# US 2025/0127953 A1 · Intraoperative uses of settable surgical compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0127953 A1
- Document ID: US20250127953A1
- Status: Published application
- Kind: A1
- Application number: 18/746,364
- Filed: 2024-06-18
- Published: 2025-04-24
- Earliest claimed: 2017-11-07
- Assignees: Abyrx, Inc.
- Applicants: Abyrx, Inc.
- Inventors: Richard L. KRONENTHAL; Aniq DARR; John PACIFICO
- Web page: https://patentgrep.com/patent/US20250127953A1

## CPC

- A61L 24/043: {Mixtures of macromolecular materials}
- A61L 24/0005: {Ingredients of undetermined constitution or reaction products thereof}
- A61L 24/0015: {Medicaments; Biocides}
- A61L 24/0042: {Materials resorbable by the body}
- A61L 24/02: containing inorganic materials
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/427: {of other specific inorganic materials not covered by A61L27/422 or A61L27/425}
- A61L 27/44: having a macromolecular matrix
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61B 2017/564: {Methods for bone or joint treatment}
- A61B 2017/883: {Means for indicating hardening of bone cement}
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/604: Biodegradation
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- C08L 33/12: Homopolymers or copolymers of methyl methacrylate
- C08L 75/04: Polyurethanes
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Provided herein are settable surgical compositions and methods for their intraoperative use.

## Claims

### Claim at position 1

-49. (canceled)

### Claim 50

A homogenous putty composition (HPC), comprising:
20-30 wt % of a polyurethane or polyurethane urea copolymer, 60-75 wt % of two or more particulate materials, and 4-10 wt % of one or more additive materials;
wherein the two or more particulate materials are selected from β-tricalcium phosphate (β-TCP), hydroxyapatite (HA), and hydroxyapatite/beta tricalcium phosphate, and
wherein the one or more additive components are selected from calcium stearate, triacetin, tocopheryl acetate, and triethanolamine.

### Claim 51 (depends on 50)

The composition of claim 50, wherein the HPC exhibits a stiffness in a range of about 4-6 millimeters for at least about 2 minutes after its formation when subjected to a penetrometer test using a force of about 50 grams applied for about 5 seconds.

### Claim 52 (depends on 50)

The composition of claim 50, wherein the HPC further comprises an anti-cancer agent, an antimicrobial agent, an antibiotic, a local anesthetic or analgesic, a statin and an anti-inflammatory agent.

### Claim 53 (depends on 50)

The composition of claim 50, wherein the HPC is fully or partially biodegradable, bioabsorbable under physiological conditions, or both fully or partially biodegradable and bioabsorbable under physiological conditions.

### Claim 54 (depends on 50)

The composition of claim 50, wherein the two or more particulate materials comprises β-tricalcium phosphate (β-TCP) and hydroxyapatite/beta tricalcium phosphate.

### Claim 55 (depends on 50)

The composition of claim 50, wherein the two or more particulate materials comprise spherical particles having a density in a range of 2-3 g/cm3 and a size in a range of 1-700 microns average diameter.

### Claim 56 (depends on 50)

The composition of claim 50, wherein one or more additive materials comprises a colorant.

### Claim 57 (depends on 52)

The composition of claim 52, wherein the antibiotic is gentamicin, clindamycin, erythromycin, ampicillin, cephalosporin, or a combination thereof.

### Claim 58 (depends on 52)

The composition of claim 52, wherein the local anesthetic or analgesic is lidocaine, bupivacaine, tetracaine, ropivacaine, or a combination thereof.

### Claim 59

A method for stabilizing a surgical screw, comprising:
providing a first reactive putty and a second reactive putty, the first reactive putty and the second reactive putty are capable of being intraoperatively mixed to form a homogenous putty composition (HPC) that is capable of filling a drilled or tapped hole for the surgical screw to be inserted into;
wherein the HPC comprises 20-30 wt % of a polyurethane or polyurethane urea copolymer, 60-75 wt % of two or more particulate materials, and 4-10 wt % of one or more additive materials,
wherein the two or more particulate materials are selected from β-tricalcium phosphate (β-TCP), hydroxyapatite (HA), and hydroxyapatite/beta tricalcium phosphate, and
wherein the one or more additive components are selected from calcium stearate, triacetin, tocopheryl acetate, and triethanolamine.

### Claim 60 (depends on 59)

The method of claim 59, wherein the HPC exhibits a stiffness in a range of about 4-6 millimeters for at least about 2 minutes after its formation when subjected to a penetrometer test using a force of about 50 grams applied for about 5 seconds.
